Dopamine dysregulation syndrome in a patient with restless legs syndrome

Sleep Medicine

Volumn 10, Issue 4, 2009, Pages 494-496

  Leu Semenescu, Smaranda ^a   Karroum, Elias ^a,b   Brion, Agnès ^a   Konofal, Eric ^a,b   Arnulf, Isabelle ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Addiction; Dopamine agonist; Dopamine dysregulation syndrome; Impulsivity; Levodopa; Restless legs syndrome

Indexed keywords

DOPAMINE RECEPTOR; LEVODOPA; PRAMIPEXOLE;

AGED; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DISEASE SEVERITY; DOPAMINE DYSREGULATION SYNDROME; DRUG ABUSE; DRUG DOSE INCREASE; DRUG OVERDOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSKINESIA; EVENING DOSAGE; HALLUCINATION; HUMAN; MALE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; REGULATORY MECHANISM; RESTLESS LEGS SYNDROME;

AGED; DOPAMINE AGENTS; HUMANS; LEVODOPA; MALE; RESTLESS LEGS SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 65349192316     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.12.010     Document Type: Article

References (10)

1. Spanagel R., and Heiling M. Addiction and its brain science. Addiction 100 (2005) 1813-1822
2. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., and Jones T. Evidence for striatal dopamine release during a video game. Nature 393 (1998) 266-268
3. Lawrence A.D., Evans A.H., and Lees A.J. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?. Lancet Neurol 2 (2003) 595-604
4. Trenkwalder C., Paulus W., and Walter A.S. The restless legs syndrome. Lancet Neurol 4 (2005) 465-475
5. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. International restless legs syndrome study group. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
6. Whiteside S.P., and Lynam D.R. The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Pers Indivi Differ 30 (2001) 669-689
7. Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9 (2008) 665-677
8. Tippmann-Peikert M., Park J.G., Boeve B.F., Shepard J.W., and Silber M.H. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68 (2007) 301-303
9. Ondo W.G., and Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 14 (2008) 28-32
10. Driver-Dunckley E., Samanta J., and Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61 (2003) 422-423